Cardiac Rhythm Management Market – Europe (2019 to 2025) Analysis, Size & Trends – ResearchAndMarkets.com


DUBLIN–()–The “Cardiac Rhythm Management Market Analysis, Size, Trends | Europe | 2019-2025” report has been added to ResearchAndMarkets.com’s offering.

In 2018, the total market for cardiac rhythm management, electrophysiology and ablation devices experienced an increase over the previous year.

Since these devices are critical life-saving apparatuses, the aging global population means continued market growth for all market segments in this report, with particularly strong growth in the electrophysiology (EP) and ablation markets. Over the forecast period, the market will maintain growth at a CAGR of in the single-digits.

The full report suite on the European market for cardiac rhythm management, electrophysiology and cardiac ablation includes pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), cardiac leads, electrophysiology (EP) lab systems, diagnostic EP catheters and cardiac ablation catheters.

Companies Mentioned

  • Abbott
  • Biosense Webster
  • Biotronik
  • Boston Scientific
  • Cardiac Science
  • GE Healthcare
  • Medtronic
  • MicroPort
  • ZOLL

Key Topics Covered:

1. EXECUTIVE SUMMARY

2. DISEASE OVERVIEW

2.1 INTRODUCTION

2.2 TYPES OF ARRHYTHMIAS

2.2.11 Atrial Fibrillation

2.2.12 Bradycardia

2.2.13 Conduction Disorders

2.2.13.1 Bundle Branch Block

2.2.13.2 Heart Block

2.2.13.3 Long QT Syndrome (LQTS)

2.2.14 Premature Contractions: PACs and PVCs

2.2.15 Tachycardia

2.2.16 Ventricular Fibrillation

2.2.17 Other Rhythm Disorders

2.2.18 Types of Arrhythmia in Children

2.3 HEART FAILURE

2.4 CARDIAC ARREST

2.5 PATIENT DEMOGRAPHICS

2.5.11 Atrial Fibrillation

2.5.12 Bradycardia

2.5.13 Conduction Disorders

2.5.14 Premature Contractions – PACs and PVCs

2.5.15 Tachycardia

2.5.16 Ventricular Fibrillation

2.5.17 Other Rhythm Disorders

3. PRODUCT ASSESSMENT

3.1 INTRODUCTION

3.2 PRODUCT PORTFOLIOS

3.2.1 Pacemakers

3.2.2 Implantable Cardioverter Defibrillators (ICDs)

3.2.3 Cardiac Resynchronization Therapy (CRT) Devices

3.2.4 Cardiac Leads

3.2.5 External Defibrillators

3.2.6 Lab Systems

3.2.6.1 Introduction

3.2.6.2 3D Mapping Systems

3.2.6.3 EP Recording Systems

3.2.6.4 Remote Steering Systems

3.2.6.5 RF Ablation Generator

3.2.6.6 ICE Systems

3.2.6.7 Product Matrix for Lab Systems: Core Companies

3.2.7 Diagnostic EP Catheters

3.2.7.1 Introduction

3.2.7.2 Diagnostic EP Catheters

3.2.7.3 ICE Catheters

3.2.8 Cardiac Ablation Catheters

3.2.8.1 Introduction

3.2.8.2 RF Ablation Catheters

3.2.8.3 Alternative Energy Catheters

3.2.8.4 High Intensity Focused Ultrasound

3.3 REGULATORY ISSUES AND RECALLS

3.3.1 Abbott

3.3.1.1 Pacemakers

3.3.1.2 Implantable Cardioverter Defibrillators (ICDs)

3.3.1.3 Cardiac Resynchronization Therapy (CRT) Devices

3.3.1.4 Cardiac Leads

3.3.1.5 EP Lab Devices

3.3.1.6 Cardiac Ablation Catheter

3.3.2 Biosense Webster

3.3.2.1 EP Lab Devices

3.3.3 Boston Scientific

3.3.3.1 Pacemakers

3.3.3.2 Implantable Cardioverter Defibrillators (ICDs)

3.3.3.3 Cardiac Resynchronization Therapy (CRT) Devices

3.3.3.4 Cardiac Leads

3.3.3.5 EP Lab Devices

3.3.3.6 RF Ablation Catheter

3.3.4 Cardiac Science

3.3.4.1 Automated External Defibrillator (AED)

3.3.5 Medtronic

3.3.6 MicroPort

3.3.7 Philips Healthcare

3.3.8 Stryker Sustainability Solutions

3.3.9 ZOLL

3.4 CLINICAL TRIALS

3.4.1 Pacemakers

3.4.2 Implantable Cardioverter Defibrillators (ICDs)

3.4.3 Cardiac Resynchronization Therapy (CRT) Devices

3.4.4 Cardiac Leads

3.4.5 External Defibrillators

3.4.6 Lab Systems

3.4.7 Diagnostic EP Catheters

3.4.8 Cardiac Ablation Catheter

4. EUROPEAN CARDIAC RHYTHM MANAGEMENT, ELECTROPHYSIOLOGY & CARDIAC ABLATION MARKET OVERVIEW

4.1 INTRODUCTION

4.2 CURRENCY EXCHANGE RATE

4.3 MARKET OVERVIEW

4.4 TREND ANALYSIS BY SEGMENT

4.5 DRIVERS AND LIMITERS

4.6 COMPETITIVE MARKET SHARE ANALYSIS

4.7 MERGERS AND ACQUISITIONS

4.8 COMPANY PROFILES

4.9 SWOT ANALYSIS

5. COUNTRY PROFILES

6. PROCEDURE NUMBERS

7. PACEMAKER MARKET

7.1 INTRODUCTION

7.1.1 Single and Dual-Chamber Devices

7.1.2 MRI-Compatible Pacemaker

7.1.3 Leadless Pacemaker

7.1.4 Initial Placement and Replacement of Pacemakers

7.2 MARKET OVERVIEW

7.3 MARKET ANALYSIS AND FORECAST

7.3.1 Total Pacemaker Market

7.3.2 Total Single-Chamber Pacemaker Market

7.3.2.1.1 Initial Placement Single-Chamber Pacemaker Market

7.3.2.1.2 Replacement Single-Chamber Pacemaker Market

7.3.3 Total Dual-Chamber Pacemaker Market

7.3.3.1.1 Initial Placement Dual-Chamber Pacemaker Market

7.3.3.1.2 Replacement Dual-Chamber Pacemaker Market

7.3.4 Leadless Pacemaker Market

7.4 PRICE ANALYSIS

7.5 DRIVERS AND LIMITERS

7.5.1 Market Drivers

7.5.2 Market Limiters

7.6 COMPETITIVE MARKET SHARE ANALYSIS

8. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET

9. CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET

10. CARDIAC LEADS MARKET

11. LAB SYSTEMS MARKET

12. DIAGNOSTIC ELECTROPHYSIOLOGY CATHETER MARKET

13. CARDIAC ABLATION CATHETER MARKET

For more information about this report visit https://www.researchandmarkets.com/r/9nm1ia



Source link